Thrombosis of the hepatic artery is a complication after liver transplantation. Oh et al identified risk factors associated with both early and late thrombosis, which can help identify those patients requiring closer monitoring and prophylaxis. The authors are from the University of Virginia in Charlottesville.
Analysis: univariate analysis followed by multivariate analysis with logistic regression.
Arterial thrombosis was defined as total disruption of the arterial blood supply to the allograft.
Classification |
Thrombosis Onset |
early |
< 1 month post-transplant |
late |
>= 1 month post-transplant |
Factors associated with early hepatic artery thrombosis:
(1) arterial anastomosis to an old conduit (using a donor iliac artery to link the aorta to the recipient's hepatic artery) in a patient requiring retransplantation
(2) ratio of recipient-to-donor body weight > 1.25
(3) biopsy proven rejection within 1 week after the transplant
(4) recipient CMV negative and donor CMV positive
Risk Factor |
Odds Ratio |
95% CI |
p value |
arterial anastomosis |
7.33 |
1.028 – 52.26 |
0.047 |
body weight ratio |
5.64 |
1.28 – 24. 9 |
0.02 |
rejection in 1 week |
2.66 |
1.16 – 6.08 |
0.02 |
CMV status |
2.81 |
1.16 – 6.84 |
0.02 |
after Table 2, page 770
Factors associated with late hepatic artery thrombosis:
(1) both recipient and donor CMV negative
(2) female donor liver to a male recipient
Risk Factor |
Odds Ratio |
95% CI |
p value |
CMV status |
2.26 |
1.33 – 3.82 |
0.002 |
female donor, male recipient |
1.97 |
1.19 – 3.24 |
0.008 |
after Table 4, page 770
where:
• In the implementation I assigned 1 point for each 2 points of the rounded odds ratio.
Interpretation:
• The more risk factors that are present, the greater the risk for thrombosis.
• Evaluation of risk factors can help optimally match donor livers with recipients to minimize the risk of thrombosis.
• Patients at risk for early thrombosis may benefit from heparin therapy during the first month after the transplant.
• Patients at risk for late thrombosis should be monitored more closely for hepatic artery blood flow and treated aggressively if worsening blood flow is detected.
Specialty: Hematology Oncology, Clinical Laboratory, Surgery, general